Aarti Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve Audited Financial Results for the quarter and half year ended September 30, 2026

Ref: ADL/SE/2026-27/55 October 27, 2026 To, To, Listing/ Compliance Department Listing/ Compliance Department BSE LTD. National Stock Exchange of India Phiroze Jeejeebhoy Towers Limited Dalal Street, “Exchange Plaza”, Plot No C/1, Mumbai 400 001 G Block, Bandra Kurla Complex, Bandra (E), Mumbai 400 051 BSE CODE: 524348 NSE SYMBOL: AARTIDRUGS Dear Sir/ Madam, Ref: Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Sub: Intimation of Board Meeting This is to inform you that next Board Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, November 3, 2026, to consider, approve and take on record Audited Financial Results for the Quarter and half year ended September 30, 2026. In pursuance to our intimation dated September 29, 2026, the trading window of the Company shall remain closed until the expiry of 48 hours after the declaration of the said Financial Results. The above information is also available on the website of the Company: www.aartidrugs.com You are requested to take the same on records. Thanking you, Yours Faithfully, FOR AARTI DRUGS LIMITED RUSHIKESH DEOLE COMPANY SECRETARY & COMPLIANCE OFFICER ICSI M. NO. F12932